Merck to Make New Investments in Singapore

Fierce Pharma (10/21/2011) Hollis, Liz Jones
Merck has signed an agreement to expand its presence in Singapore through new manufacturing, marketing and research investments. Under the agreement, Merck will invest more than $250 million over the next 10 years in site improvements at its manufacturing facilities in Tuas. It will also expand its biotech operations, adding capability to support new product launches.

Read the complete article

Share |

Sponsor Highlights